Enchem (348370) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Apr, 2026Executive summary
Revenue for FY2023 was ₩424.7 billion, down 16.6% year-over-year, with operating income dropping 66.6% to ₩5.1 billion and a net loss of ₩49.2 billion, reversing a prior year profit.
The company’s core business is the manufacture and sale of electrolyte solutions for secondary batteries, with global operations and major customers in the battery and automotive sectors.
Significant investments were made in overseas plant expansions and new business areas, including NMP recycling and joint ventures for raw material supply.
Financial highlights
Total assets increased 30.3% year-over-year to ₩886.9 billion, while total liabilities rose 54.2% to ₩596.8 billion.
Cash and cash equivalents at year-end were ₩45.7 billion, up from ₩33.3 billion the previous year.
Gross margin remained stable at ₩50.1 billion, but operating margin contracted sharply due to higher SG&A and financial costs.
Major financial activities included issuance of convertible bonds and rights offering, with significant capital expenditures for capacity expansion.
Outlook and guidance
The company expects continued growth in the global EV and battery markets, with further expansion of overseas production capacity and new business lines.
Management is focused on strengthening supply chain stability and cost competitiveness through vertical integration and recycling initiatives.
Latest events from Enchem
- Revenue fell and losses continued, raising material uncertainty about going concern.348370
Q2 2026 - H1 2024 saw a sharp revenue drop and large net loss amid global expansion and new investments.348370
Q2 2024 - 2024 Q3 saw steep revenue decline and heavy net loss, but global expansion and R&D continue.348370
Q3 2024 - Q1 2025 saw a sharp revenue drop but strong net profit from non-operating gains.348370
Q1 2025 - Net profit returned to positive despite lower sales, with global expansion and R&D ongoing.348370
Q3 2025 - 2024 saw a steep revenue drop, heavy net loss, and major impairments amid persistent market risks.348370
Q4 2024 - Revenue declined and operating loss posted, but net profit achieved via non-operating gains.348370
Q2 2025